Indications/Uses
Decreased GI motility.
|
Dosage/Direction for Use
Adult: PO As anhydrous citrate: 5 mg 3 times/day.
|
Special Precautions
Continuous admin of this drug is not recommended if no improvement in GI symptoms is observed after 2 wk of admin. Elderly, renal impairment, hepatic impairment.
|
Adverse Reactions
Diarrhoea, abdominal pain; dizziness; constipation; headache; insomnia; nausea.
|
Drug Interactions
Mosapride concentration increased by erythromycin. May increase risk of QT prolongation with QT prolonging drugs.
|
ATC Classification
A03FA09 - mosapride
|